Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients-Reference-Cited by-同舟云学术

Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients

Published:2014-01-07 Issue:1 Volume:3 Page:124-133
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zheng Zhiyuan¹,Hanna Nader²,Onukwugha Eberechukwu¹,Reese Emily S.¹,Seal Brian³,Mullins C. Daniel¹

Affiliation:

1. Department of Pharmaceutical Health Services Research; University of Maryland School of Pharmacy; Baltimore MD

2. Department of Surgery; Division of General and Oncologic Surgery; University of Maryland School of Medicine; Baltimore MD

3. Bayer Healthcare Pharmaceuticals Inc.; Wayne NJ

Funder

Bayer Healthcare Pharmaceuticals, Inc.

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.176/fullpdf

Reference29 articles.

1. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer;Rothenberg;J. Clin. Oncol.,1996

2. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer;Cunningham;Lancet,1998

3. Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer;Rougier;Lancet,1998

4. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer;Fuchs;J. Clin. Oncol.,2003

5. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen;André;J. Clin. Oncol.,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis;BMC Medicine;2020-10-23

2. Patient-level Factors Associated With the Initial Management of Older Adults Diagnosed With Follicular Lymphoma: A Surveillance, Epidemiology, and End Results–Medicare Analysis;Clinical Lymphoma Myeloma and Leukemia;2020-04

3. Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges;Clinics;2018-10-09

4. Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients;Journal of Managed Care & Specialty Pharmacy;2016-06

5. Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients;Advances in Therapy;2014-07